MedTrace Logo

Clinical Impact of an Antibiotic Stewardship Program in a Neonatal Intensive Care Unit

NCT04039152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-04-23

No results posted yet for this study

Summary

Antimicrobial resistance is one of the biggest and most urgent threat to global health. Initiating antimicrobial stewardship programs is one of the main efforts to control antimicrobial resistance. Implementing these programs in neonatal intensive care units (NICU)is very important and crucial despite of its difficulty, where antibiotics are used extensively. The aim of present study was to assess the clinical impact of implementing antibiotic stewardship program interventions at NICU.

Conditions

  • Neonatal Sepsis

Interventions

OTHER

locally adapted neonatal sepsis treatment protocol

the neonatal sepsis treatment protocol was modified according to the local antibiotics susceptibility patterns

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Neveen H. Abdelaal, M.sc. · Department of Pharmacy and Medical Supplies, Assiut University Children's Hospital, Egypt

  • Nafisa H. Abdel Aziz, PhD · Department of Pediatrics, Faculty of Medicine, Assiut University, Egypt

  • Asmaa M. Abdelaziz, PhD · Department of Clinical Pathology, Faculty of Medicine, Assiut University, Egypt

  • Sahar B. Khalil, PhD · Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Egypt

  • Mohamed M Abdel-Latif, PhD · Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Egypt

Eligibility

Min Age
1 Day
Max Age
30 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04039152 on ClinicalTrials.gov